Basic Information
| LncRNA/CircRNA Name | LINC00963 |
| Synonyms | NA |
| Region | GRCh38_9:129483451-129513686 |
| Ensemble | ENSG00000204054 |
| Refseq | NR_038955 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qRT-PCR, Western blot |
| Sample | OC tissues,cell lines (A2780, TOV112D, OVCAR-3 and SKOV3) |
| Expression Pattern | up-regulated |
| Function Description | LINC00963 displayed a close relation- ship with unfavorable prognosis, and it was prominently raised in OC tissues of patients with lymph node metastasis. |
| Pubmed ID | 32021459 |
| Year | 2020 |
| Title | LINC00963 Promotes Ovarian Cancer Proliferation, Migration and EMT via the miR-378g /CHI3L1 Axis |
External Links
| Links for LINC00963 | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |